Safety and Efficacy of OMS643762 in Subjects With Huntington's Disease

Summary

The purpose of this study is to determine the safety, tolerability and pharmacokinetics of OMS643762 (the study drug) in subjects with Huntington's disease (HD).

Timeline

Start

2014-01

Primary completion

2014-10-15

Completion

2014-10-15

Outcome

Outcome not reported

Stopped (Business): “Sponsor decision - pending further analysis of available data”

Drugs

Indications